# FDA Inspection 1166854 - Amit (nmi)Mahipal MD - March 22, 2022

Source: https://www.keypedia.com/records/fda_inspections/amit-nmimahipal-md/19e7797a-5717-4d33-957b-f529cbe1f9db
Source feed: FDA_Inspections

> FDA Inspection 1166854 for Amit (nmi)Mahipal MD on March 22, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166854
- Company Name: Amit (nmi)Mahipal MD
- Inspection Date: 2022-03-22
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1092259 - 2019-05-21](https://www.keypedia.com/records/fda_inspections/amit-nmimahipal-md/80642ba9-9f6f-400f-bfe1-7d9d89a11518)

Company: https://www.keypedia.com/companies/amit-nmimahipal-md/681d5098-1f30-4d28-ab6b-c72172bef271

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c